Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Dmitriy Gorenshteyn"'
Autor:
Yuanfang Guan, Dmitriy Gorenshteyn, Margit Burmeister, Aaron K Wong, John C Schimenti, Mary Ann Handel, Carol J Bult, Matthew A Hibbs, Olga G Troyanskaya
Publikováno v:
PLoS Computational Biology, Vol 8, Iss 9, p e1002694 (2012)
Integrated analyses of functional genomics data have enormous potential for identifying phenotype-associated genes. Tissue-specificity is an important aspect of many genetic diseases, reflecting the potentially different roles of proteins and pathway
Externí odkaz:
https://doaj.org/article/cd24d7aa560e4a8ab919491b64fa491f
Autor:
Bobby Daly, Kevin Nicholas, Jessica Flynn, Nicholas Silva, Katherine Panageas, Jun J. Mao, Lior Gazit, Dmitriy Gorenshteyn, Stefania Sokolowski, Tiffanny Newman, Claire Perry, Isaac Wagner, Alice Zervoudakis, Rori Salvaggio, Jessie Holland, Yeneat O. Chiu, Gilad J. Kuperman, Brett A. Simon, Diane L. Reidy-Lagunes, Wendy Perchick
Publikováno v:
JAMA Network Open. 5:e221078
Electronic patient-reported outcomes (ePROs) may have the potential to improve cancer care delivery by enhancing patient quality of life, reducing acute care visits, and extending overall survival. However, the optimal cadence of ePRO assessments is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bdf1bed1302e866830d2c59cd883422
https://doi.org/10.1001/jamanetworkopen.2022.1078
https://doi.org/10.1001/jamanetworkopen.2022.1078
Autor:
Wendy Perchick, Kevin Nicholas, Lauren L. Katzen, Claire Perry, Stefania Sokolowski, Dmitriy Gorenshteyn, Isaac Wagner, Alice Zervoudakis, Diane Reidy-Lagunes, Lynn Adams, Rori Salvaggio, Margarita Rozenshteyn, Han Xiao, Lior Gazit, Brett A Simon, Yeneat O. Chiu, Bobby Daly, Abigail Baldwin Medsker
Publikováno v:
JCO Clin Cancer Inform
PURPOSE To create a risk prediction model that identifies patients at high risk for a potentially preventable acute care visit (PPACV). PATIENTS AND METHODS We developed a risk model that used electronic medical record data from initial visit to firs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::168069f320537b0cb92b8c1c3ee80118
https://pubmed.ncbi.nlm.nih.gov/32213093
https://pubmed.ncbi.nlm.nih.gov/32213093
Autor:
Chandra L. Theesfeld, Olga G. Troyanskaya, Vessela N. Kristensen, Dmitriy Gorenshteyn, Amy C. Durham, James A. Cahill, John D. Storey, Julien Funk, Kiley Graim, Rumela Chakrabarti, David G. Robinson, Michael H. Goldschmidt, Karin U. Sorenmo, Nicholas J. Carriero
Publikováno v:
Genome Res
Understanding the changes in diverse molecular pathways underlying the development of breast tumors is critical for improving diagnosis, treatment, and drug development. Here, we used RNA-profiling of canine mammary tumors (CMTs) coupled with a robus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f93ca6f5fb7858678a3a5c8a7c5d0571
https://pubmed.ncbi.nlm.nih.gov/33361113
https://pubmed.ncbi.nlm.nih.gov/33361113
Autor:
Maria E. Arcila, Gerald A. Soff, Andrew Dunbar, Mark T.A. Donoghue, Dmitriy Gorenshteyn, Simon Mantha, Kelly L. Bolton, Sean M. Devlin
Publikováno v:
Blood. 136:37-37
Background: Several clinical prediction scores have been designed to assess the risk of cancer-associated thrombosis (CAT). The most commonly used in current clinical practice is the Khorana score, however it is applicable only to patients prior to i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39caad0ba093ea948dc7bb90e06e123d
https://doi.org/10.1182/blood-2020-138579
https://doi.org/10.1182/blood-2020-138579
Autor:
Chandra L. Theesfeld, Nicholas Carriero, Olga G. Troyanskaya, Amy C. Durham, Kiley Graim, Vessela N. Kristensen, John D. Storey, Dmitriy Gorenshteyn, Julien Funk, David G. Robinson, Karin U. Sorenmo, Michael H. Goldschmidt, Rumela Chakrabarti, James A. Cahill
Publikováno v:
Cancer Research. 80:2504-2504
Malignancy in cancer is a consequence of the progressive accumulation of mutations in a tumor, with profound implications for drug selection and treatment. However, in human studies, inter-patient variability obscures molecular signatures of tumor pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b14aeed78de6d83c7636b447ffaf0523
https://doi.org/10.1158/1538-7445.am2020-2504
https://doi.org/10.1158/1538-7445.am2020-2504
Autor:
Dmitriy Gorenshteyn, Yeneat O. Chiu, Abigail Baldwin-Medsker, Bobby Daly, Isaac Wagner, Wendy Perchick, Rori Salvaggio, Stefania Sokolowski, Lior Gazit, Han Xiao, Alice Zervoudakis, Diane Lauren Reidy, Kevin Nicholas, Lauren L. Katzen, Jennie Matays, Brett A Simon, Judith E Nelson, Kenneth K.-S. Ng, Mikel Ross, Kimberly Chow, Lynn Adams
Purpose: The Centers for Medicare & Medicaid Services (CMS) identifies suboptimal management of treatment toxicities as a care gap and proposes the measurement of hospital performance on the basis of emergency department visits for 10 common symptoms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc36f107985566d762e4c1de2cfae1da
https://europepmc.org/articles/PMC6804915/
https://europepmc.org/articles/PMC6804915/
Autor:
Wendy Perchick, Stefania Sokolowski, Yeneat O. Chiu, Kevin Nicholas, Jessie C. Holland, Rori Salvaggio, Lynn Adams, Abigail Baldwin, Lauren L. Katzen, Robert Michael Daly, Alice Zervoudakis, Lior Gazit, Margarita Rozenshteyn, Brett A Simon, Han Xiao, Isaac Wagner, Claire Perry, Dmitriy Gorenshteyn, Diane Lauren Reidy
Publikováno v:
Journal of Clinical Oncology. 37:6554-6554
6554 Background: Acute care accounts for half of cancer expenditures and is a measure of poor quality care. Identifying patients at high risk for emergency department (ED) visits enables institutions to target resources to those most likely to benefi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e9a332b275f34c8a55999e8de27c4af
https://doi.org/10.1200/jco.2019.37.15_suppl.6554
https://doi.org/10.1200/jco.2019.37.15_suppl.6554
Autor:
Lior Gazit, Isaac Wagner, Wendy Perchick, Stefania Sokolowski, Dmitriy Gorenshteyn, Brett A Simon, Lauren L. Katzen, Claire Perry, Diane Lauren Reidy, Kevin Nicholas, Lynn Adams, Abigail Baldwin, Robert Michael Daly, Yeneat O. Chiu
Publikováno v:
Journal of Clinical Oncology. 36:144-144
144 Background: Acute care accounts for half of cancer expenditures and is a measure of poor quality care. Identifying patients at high risk for ED visits enables institutions to target symptom management resources to those most likely to benefit. Ri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5eccc8a806f566b7aa1bd1ae2e5f58c
https://doi.org/10.1200/jco.2018.36.34_suppl.144
https://doi.org/10.1200/jco.2018.36.34_suppl.144
Autor:
Dmitriy Gorenshteyn, Lauren L. Katzen, Brett A Simon, Diane Lauren Reidy, Lynn Adams, Isaac Wagner, Abigail Baldwin, Yeneat O. Chiu, Wendy Perchick, Stefania Sokolowski, Kevin Nicholas, Robert Michael Daly, Lior Gazit, Claire Perry
Publikováno v:
Journal of Clinical Oncology. 36:314-314
314 Background: Acute care accounts for half of cancer expenditures and is a measure of poor quality care. Identifying patients at high risk for ED visits enables institutions to target symptom management resources to those most likely to benefit. Ri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66890237989a909ad0169d2f7072f4c1
https://doi.org/10.1200/jco.2018.36.30_suppl.314
https://doi.org/10.1200/jco.2018.36.30_suppl.314